Stephens Investment Management Group LLC Ligand Pharmaceuticals Inc Transaction History
Stephens Investment Management Group LLC
- $7.11 Billion
- Q2 2025
A detailed history of Stephens Investment Management Group LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Stephens Investment Management Group LLC holds 604,813 shares of LGND stock, worth $112 Million. This represents 0.97% of its overall portfolio holdings.
Number of Shares
604,813
Previous 607,222
0.4%
Holding current value
$112 Million
Previous $63.8 Million
7.69%
% of portfolio
0.97%
Previous 0.97%
Shares
33 transactions
Others Institutions Holding LGND
# of Institutions
290Shares Held
19.5MCall Options Held
9KPut Options Held
0-
Black Rock Inc. New York, NY2.87MShares$530 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$385 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.06MShares$196 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3927KShares$171 Million0.13% of portfolio
-
State Street Corp Boston, MA750KShares$138 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $3.11B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...